| Eric E Loy, MD | |
|
360 Keen Street, Burkesville, KY 42717 | |
| (270) 864-2889 | |
| (270) 864-2229 |
| Full Name | Eric E Loy |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 23 Years |
| Location | 360 Keen Street, Burkesville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548297393 | NPI | - | NPPES |
| 64060106 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 37436 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cumberland Family Medical Center, Inc. | 6305947789 | 94 |
News Archive
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its New Drug Application Topicort (desoximetasone) Topical Spray, 0.25%.
Antares Pharma, Inc. today announced the New Drug Application (NDA) for Anturol® Gel in patients with overactive bladder (OAB) was accepted for filing for review by the U.S. Food and Drug Administration (FDA). Anturol is an oxybutynin gel incorporating Antares' ATD Gel technology.
Isotechnika Pharma Inc. today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) filed by its partner, Lux Biosciences, Inc., for voclosporin. Following validation of the MAA, the dossier is distributed to members of the Committee for Medicinal Products for Human Use (CHMP) for formal review, which is expected to take one year.
New research raises troubling concerns about the use of aggressive drug therapies to treat a wide range of diseases such as MRSA, C. difficile, malaria, and even cancer.
At the Faculty of Pharmacy of the Basque Public University (UPV/EHU) the Pharmacokinetics, Nanotechnology and Gene Therapy research team is using nanotechnology to develop new formulations that can be applied to drugs and gene therapy.
› Verified 1 days ago
| Entity Name | Cumberland Family Medical Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306873500 PECOS PAC ID: 6305947789 Enrollment ID: O20120221000433 |
News Archive
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its New Drug Application Topicort (desoximetasone) Topical Spray, 0.25%.
Antares Pharma, Inc. today announced the New Drug Application (NDA) for Anturol® Gel in patients with overactive bladder (OAB) was accepted for filing for review by the U.S. Food and Drug Administration (FDA). Anturol is an oxybutynin gel incorporating Antares' ATD Gel technology.
Isotechnika Pharma Inc. today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) filed by its partner, Lux Biosciences, Inc., for voclosporin. Following validation of the MAA, the dossier is distributed to members of the Committee for Medicinal Products for Human Use (CHMP) for formal review, which is expected to take one year.
New research raises troubling concerns about the use of aggressive drug therapies to treat a wide range of diseases such as MRSA, C. difficile, malaria, and even cancer.
At the Faculty of Pharmacy of the Basque Public University (UPV/EHU) the Pharmacokinetics, Nanotechnology and Gene Therapy research team is using nanotechnology to develop new formulations that can be applied to drugs and gene therapy.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric E Loy, MD Po Box 1080, Burkesville, KY 42717-1080 Ph: (270) 864-1472 | Eric E Loy, MD 360 Keen Street, Burkesville, KY 42717 Ph: (270) 864-2889 |
News Archive
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its New Drug Application Topicort (desoximetasone) Topical Spray, 0.25%.
Antares Pharma, Inc. today announced the New Drug Application (NDA) for Anturol® Gel in patients with overactive bladder (OAB) was accepted for filing for review by the U.S. Food and Drug Administration (FDA). Anturol is an oxybutynin gel incorporating Antares' ATD Gel technology.
Isotechnika Pharma Inc. today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) filed by its partner, Lux Biosciences, Inc., for voclosporin. Following validation of the MAA, the dossier is distributed to members of the Committee for Medicinal Products for Human Use (CHMP) for formal review, which is expected to take one year.
New research raises troubling concerns about the use of aggressive drug therapies to treat a wide range of diseases such as MRSA, C. difficile, malaria, and even cancer.
At the Faculty of Pharmacy of the Basque Public University (UPV/EHU) the Pharmacokinetics, Nanotechnology and Gene Therapy research team is using nanotechnology to develop new formulations that can be applied to drugs and gene therapy.
› Verified 1 days ago
Lauren Dyer-hurt, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 299a Glasgow Rd, Burkesville, KY 42717 Phone: 270-864-2555 Fax: 270-864-3777 | |
Dr. Robert Flowers, M D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 Keen Street, Burkesville, KY 42717 Phone: 270-864-3371 Fax: 270-864-5667 | |
Samuel L Rice, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 349 Keen Street, Burkesville, KY 42717 Phone: 270-864-5102 Fax: 270-864-1739 | |
Mr. Joseph Dee Skipworth, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1100 Judio Road, Burkesville, KY 42717 Phone: 270-433-6177 | |
Christian D Konsavage, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 299a Glasgow Rd, Burkesville, KY 42717 Phone: 270-864-2555 Fax: 270-864-3777 |